Insight Molecular Diagnostics Inc.
IMDXNASDAQHealthcareDiagnostics & Research
As of Oct 23, 2026 close
- Market cap
- $104.00M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $2.42$8.51
- Volume (live)
- -
- Avg. volume (3M)
- 312.50K
Insight Molecular Diagnostics (IMDX) Stock Price & Financial Analysis
Insight Molecular Diagnostics Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $2.76 - $2.92 |
|---|---|
| 52-Week High | $8.51 |
| 52-Week Low | $2.42 |
| Open | $2.84 |
| Volume (last close) | 42.48K |
| Average Volume (3M) | 312.50K |
| Revenue (TTM) | 1.67M |
|---|---|
| Net Income (TTM) | -49.36M |
| Free Cash Flow (TTM) | -31.00M |
| EPS (TTM) | −$1.46 |
| Profit Margin | -2955.63% |
| Operating Margin | -2217.90% |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 104.00M |
|---|---|
| Shares Outstanding | 36.75M |
| Price to Sales (P/S) | 62.28 |
| Price to Book (P/B) | -4.88 |
| EV/EBITDA | -1.91 |
| 50-Day MA | $3.82 |
|---|---|
| 200-Day MA | $4.91 |
| 1-Year Change | −55.76% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Insight Molecular Diagnostics at a Glance
As of the Oct 23, 2026 close, Insight Molecular Diagnostics (IMDX) has a market capitalization of $104.00M. The stock trades at 62.3× sales. Over the trailing twelve months it lost $49.36M on revenue of $1.67M and burned $31.00M of free cash flow. Revenue fell 60.8% year over year.
As of its latest reported balance sheet, it holds $17.76M in cash and securities against $2.63M of debt, a net cash position of $15.13M.
Insight Molecular Diagnostics does not currently pay a dividend.
The share price is down 55.8% over the past year. At $2.83 (the Oct 23, 2026 close) it sits near the bottom of its 52-week range of $2.42 to $8.51, below its 200-day moving average of $4.91.
Frequently Asked Questions About Insight Molecular Diagnostics
What is the current stock price for IMDX?
As of the Oct 23, 2026 close, IMDX stock trades at $2.83. The 52-week range is $2.42–$8.51, with a day range of $2.76–$2.92.
What is the P/E ratio for IMDX?
The P/E ratio (Price-to-Earnings) for IMDX is shown in the Key Statistics section. This valuation metric helps compare Insight Molecular Diagnostics Inc. to industry peers.
Does IMDX pay dividends?
Insight Molecular Diagnostics does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for IMDX?
Analyst ratings and recommendations for IMDX are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of IMDX?
As of the Oct 23, 2026 close, Insight Molecular Diagnostics's market capitalization is $104.0M, classifying it as a micro-cap company. Insight Molecular Diagnostics operates in the Healthcare sector within the Diagnostics & Research industry.